Literature DB >> 11313937

Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene.

R Ruediger1, H T Pham, G Walter.   

Abstract

Protein phosphatase 2A (PP2A) consists of three subunits, A, B and C. The A and B subunits have regulatory functions while C is the catalytic subunit. PP2A core enzyme is composed of subunits A and C, and the holoenzyme of subunits A, B and C. All subunits exist as multiple isoforms or splice variants. The A subunit exists as two isoforms, A alpha and A beta. Here we report about the properties of eight A beta mutants, which were found in human lung and colon cancer. These mutants were reconstructed by site-directed mutagenesis and assayed for their ability to bind B and C subunits. Two mutants showed decreased binding of PR72, a member of the B" family of B subunits, but normal C subunit binding; two mutants exhibited decreased binding of the C subunit and of B"/PR72; and one mutant showed increased binding of both the C subunit and B"/PR72. Of three mutants that behaved like the wild-type A beta subunit, one is a polymorphic variant and another one is altered outside the binding region for B and C subunits. Importantly, we also found that the wild-type A alpha and A beta isoforms, although 85% identical, are remarkably different in their ability to bind B and C subunits. Our findings may have important implications in regard to the role of PP2A as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313937     DOI: 10.1038/sj.onc.1204279

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

1.  PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development.

Authors:  Zhigang Jin; Lindsay Wallace; Scott Q Harper; Jing Yang
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

2.  Identification of PP2A complexes and pathways involved in cell transformation.

Authors:  Anna A Sablina; Melissa Hector; Nathalie Colpaert; William C Hahn
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

3.  Comparisons between murine polyomavirus and Simian virus 40 show significant differences in small T antigen function.

Authors:  Shaida Andrabi; Justin H Hwang; Jennifer Kean Choe; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

4.  PR72, a novel regulator of Wnt signaling required for Naked cuticle function.

Authors:  Menno P Creyghton; Giulietta Roël; Pieter J A Eichhorn; E Marielle Hijmans; Irma Maurer; Olivier Destrée; René Bernards
Journal:  Genes Dev       Date:  2005-02-01       Impact factor: 11.361

Review 5.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

Review 6.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

7.  Restricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.

Authors:  Hyun Jin Kwun; Masahiro Shuda; Carlos J Camacho; Armin M Gamper; Mamie Thant; Yuan Chang; Patrick S Moore
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

Review 8.  Protein phosphatase 2A: a target for anticancer therapy.

Authors:  Danilo Perrotti; Paolo Neviani
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

9.  Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.

Authors:  Hugh K Arnold; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  Transcriptional regulation of PP2A-A alpha is mediated by multiple factors including AP-2alpha, CREB, ETS-1, and SP-1.

Authors:  He-Ge Chen; Wen-Jun Han; Mi Deng; Jichao Qin; Dan Yuan; Jin-Ping Liu; Ling Xiao; Lili Gong; Songping Liang; Jian Zhang; Yun Liu; David Wan-Cheng Li
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.